Emerging strategies and options: Difference between revisions
From MalariaETC
No edit summary |
No edit summary |
||
| (28 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{ | {{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}} | ||
---- | |||
'''Navigation'''</br> | |||
<span style="font-size:90%">[[MalariaETC Index|Main Malaria Index]]''</span></br> | |||
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|RDT main page]]''</span></br> | |||
<span style="font-size:90%">>[[RDT_test:_formats_of_tests|RDT Test Design]]''</span></br> | |||
<span style="font-size:90%">>>Current page: '''New RDT Design strategies'''</span> | |||
---- | |||
{| class="wikitable" style="widthe:90%; border-style: solid; border-width: 4px; border-color:teal" | |||
|colspan="1" style = "font-size:140%; color:black; background: FFFAFA"|<span style="color:black>'''Emerging Strategies for RDT design'''</span> | |||
---- | ---- | ||
<span style="font-size:90%"> | <span style="font-size:90%">'''Multiplexed detection strategies''' | ||
</br>These may be used in some circumstances to optimise performance according to local requirements:</br></br> (a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, then tests with specificity for each species may prove valuable - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH) may be combined with or without a pan-specific antibody. This can offer some advantages in detecting dual infection by the two species.</br></br>(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances. | |||
|} | |||
Latest revision as of 10:25, 30 September 2024
Navigation
Main Malaria Index
RDT main page
>RDT Test Design
>>Current page: New RDT Design strategies
| Emerging Strategies for RDT design
Multiplexed detection strategies
|